CURA — Curaleaf Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Curaleaf Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	221	627	1,196	1,275	1,347
Cost of Revenue
Gross Profit	43.9	166	570	626	614
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	249	576	1,173	1,293	1,369
Operating Profit	-27.7	51	22.7	-17.4	-22.1
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-45.8	30.8	-62.2	-86.5	-124
Provision for Income Taxes
Net Income After Taxes	-69.8	-56.8	-215	-265	-239
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-67.2	-57.2	-206	-370	-281
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-67.2	-57.2	-206	-370	-281
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.251	-0.343	-0.257	-0.288	-0.251